AVB Stock Recent News
AVB LATEST HEADLINES
REIT investors must pay close attention to real estate trends. The office sector remains a mess and likely will for a long time to come. Multifamily is suffering temporarily, but 2025 could be a lot better.
U.S. equity markets extended gains to a fifth-straight week despite a continued upswell in benchmark interest rates, as investors weighed a solid start to earnings season against lukewarm inflation data. All eyes were on the Consumer Price Index report, which posted a fractional upside surprise in September for a second-straight month, which followed four straight months of cooler-than-expected reports. Bond markets remained under pressure as buoyant labor market data last week and lukewarm inflation data this week has prompted investors to re-think the prospects of aggressive Fed rate cuts.
Astellas receives an exclusive option to license AVB-101, an investigational, AAV-based gene therapy in Phase 1/2 development AviadoBio receives $20 million equity investment, up to $30 million in upfront payments and is eligible to receive up to $2.18 billion in license fees and milestone payments plus royalties if Astellas exercises its option LONDON and TOKYO , Oct. 8, 2024 /PRNewswire/ -- AviadoBio Ltd. ("AviadoBio") and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced an exclusive option and license agreement for AVB-101, an investigational, AAV-based gene therapy in Phase 1/2 development for patients with frontotemporal dementia with progranulin mutations (FTD-GRN).
ARLINGTON, Va.--(BUSINESS WIRE)--AVALONBAY COMMUNITIES, INC. (NYSE: AVB) (the “Company”) will release its third quarter 2024 earnings on November 4, 2024 after the market close. The Company will hold a conference call on November 5, 2024 at 11:00 AM Eastern Time (ET) to discuss its third quarter 2024 results. Live Conference Call Details Domestic: (877) 407-9716 International: (201) 493-6779 Webcast: https://investors.avalonbay.com Details for the Replay of the Conference Call Domestic: (844).
AvalonBay's premium high-quality assets amid favorable demographic trends is an upside. However, high supply and a decelerating effective rent change ail.
AvalonBay's stock dropped significantly during the rate hike cycle but soared when rate cut expectations began in November. Strong occupancy rates and rising net operating income highlight AvalonBay's robust performance, supported by macro trends like delayed family formation and cheaper rent versus mortgage payments. With the stock price being just 11% away from all-time highs, the dividend yield is considerably lower than its history, making the stock a hold.
AVB benefits from a solid demand for its high-quality assets, technological improvements and a healthy balance sheet despite an elevated supply of rental units.
U.S. equity markets posted their worst week since March 2023 while benchmark interest rates tumbled to eighteen-month lows after employment data indicated a further cooling in economic momentum. Among several disappointing reports, BLS Nonfarm Payrolls data showed that the U.S. economy added just 142k jobs in August, while prior months were again revised sharply lower. Snapping a four-week winning streak that lifted the major benchmark to the cusp of record highs, the S&P 500 tumbled 4.1% this week. Technology stocks dragged on the downside.
ARLINGTON, Va.--(BUSINESS WIRE)--AVALONBAY COMMUNITIES, INC. (NYSE: AVB) (the “Company”) announced today that Benjamin W. Schall, the Company's CEO and President, and select members of the Company's management team will be participating in a roundtable discussion at Bank of America's Global Real Estate Conference on Tuesday, September 10, 2024, at 10:20 A.M. Eastern Time. During this event, management may discuss the Company's current operating environment and trends; development, redevelopment.
ARLINGTON, Va.--(BUSINESS WIRE)--AVALONBAY COMMUNITIES, INC. (NYSE: AVB) (the “Company”) announced today that it has priced an underwritten public offering of 3,200,000 shares of common stock, all of which are being offered in connection with the forward sale agreements described below, for expected gross proceeds of approximately $710.4 million. Goldman Sachs & Co. LLC, BofA Securities, Deutsche Bank Securities Inc. and Morgan Stanley are acting as joint book-running managers for the offer.